Evidence map›Paper›PMID 41413365›Full record

ArticleInternational journal of behavioral medicine2025

Patient Perspectives Toward a Decision Aid for Radioactive Iodine Treatment for Intermediate Risk Thyroid Cancer.

Alaina L Carr, Kate L Gabriel, Gautham Pillai, James Pocchia, Kristi D Graves, Jacqueline Jonklaas

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of behavioral medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alaina L CarrGeorgetown University Medical Center, Department of Oncology, Washington, DC, United States. alc343@georgetown.edu.
Kate L GabrielGeorgetown University School of Health, Department of Health Systems Administration, Washington, DC, United States.
Gautham PillaiGeorgetown University School of Health, Department of Human Science, Washington, DC, United States.
James PocchiaGeorgetown University Medical Center, Department of Oncology, Washington, DC, United States.
Kristi D GravesGeorgetown University Medical Center, Department of Oncology, Washington, DC, United States.
Jacqueline JonklaasDivision of Endocrinology, Georgetown University, Washington, DC, United States.

Funding

Capturing the Impact of Craniofacial Damage after Radioiodine TherapyR01DE025822 · NIDCR · GEORGETOWN UNIVERSITY · PI GRAVES, KRISTI D., JONKLAAS, JACQUELINE · 2016 to 2020
$1.3M
Training Program in Cancer Population Science (CaPS)T32CA261787 · NCI · GEORGETOWN UNIVERSITY · PI Lucile L. Adams-Campbell, Suzanne C. O'Neill · 2021 to 2026
$1.1M
Use of a decision aid to resolve uncertainty about radioactive iodine treatment in patients with intermediate-risk thyroid cancer: the Radiance trialUG3DE031248 · NIDCR · GEORGETOWN UNIVERSITY · PI GRAVES, KRISTI D., JONKLAAS, JACQUELINE · 2022 to 2023
$653k
The development of a technology-based information support intervention (iSupport) among patients with differentiated thyroid cancer post radioactive iodine therapyK99CA277588 · NCI · GEORGETOWN UNIVERSITY · PI CARR, ALAINA L · 2023 to 2024
$255k
NCI NIH HHS K99 CA277588NCI NIH HHS T32 CA261787NCI NIH HHS T32CA261787NIDCR NIH HHS R01 DE025822NIDCR NIH HHS R01DE025822NIDCR NIH HHS UG3 DE031248
6 · The paper itself

Abstract

backgroundPatients with intermediate risk thyroid cancer face the decision of whether or not to undergo radioactive iodine (RAI) treatment after total thyroidectomy. This process is challenging due to the unclear risks and benefits of RAI treatment for intermediate risk disease. The study identified the decisional needs of patients offered RAI treatment for thyroid cancer to inform the development of a web-based patient decision aid (PtDA).

methodWe used purposive sampling to recruit 23 adult patients with thyroid cancer (M

conclusionThe study provides patient insights for a targeted web-based PtDA that integrates personal values, risk information, and logistical considerations to support informed decision-making about RAI treatment. Future research to examine the benefits of PtDAs for treatment of intermediate-risk thyroid cancer is needed.

Indexed as

CancerDecision support techniquesIodine radioisotopesOncologyPatient-centered careThyroid neoplasm

Identifiers

PMID41413365
PMCPMC13077738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.